ArticleFrontiers in cellular and infection microbiology2026
DETECTX: a novel deep learning approach for detecting pneumonia, tuberculosis, and aspergillosis from chest X-rays.
Article in Frontiers in cellular and infection microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Aspergillosis, pneumonia, and tuberculosis are distinct respiratory illnesses, but they share similar symptoms, including cough, fever, and shortness of breath. This overlap can make accurate diagnosis challenging. Delayed or incorrect identification, particularly of aspergillosis, can lead to worsening patient outcomes and significant lung damage. Methods: To address this diagnostic challenge, we developed a deep learning based system designed to differentiate between aspergillosis, pneumonia, tuberculosis, and healthy lungs using chest X-ray images. We implemented three models: Convolutional Neural Networks (CNN), ResNet-50, and a novel Siamese Convolutional Neural Network. The models were trained on a dataset of 7,200 images, categorized into four groups: aspergillosis, pneumonia, tuberculosis, and healthy. We utilized various training-testing ratios to optimize performance, which was evaluated using accuracy, precision, recall, F1-score, and confusion matrices. Results: Among the models tested, the Siamese neural network outperformed the others, achieving an accuracy of 98.72%, surpassing the performance of state-of-the-art models in comparative studies. Conclusion: The novel Siamese CNN model demonstrated excellent accuracy in differentiating respiratory diseases from chest X-ray images, offering a promising tool for more accurate and timely diagnoses. We also developed an intuitive web interface that enables healthcare providers to upload and analyze medical images, facilitating quicker and more reliable diagnoses to support timely interventions.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.